REQUEST A DEMO
Total
USD $0.00
Search more companies

Herba Drug, s.r.o. (Slovakia)

Main Activities: Toilet Preparation Manufacturing
Full name: Herba Drug, s.r.o. Profile Updated: April 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Herba Drug, s.r.o. is based in Slovakia, with the head office in Smizany. The company operates in the Toilet Preparation Manufacturing sector. The company was established on April 30, 1997. The total number of employees is currently 50 - 99 (2023). The company’s latest financial report indicates a net sales revenue increase of 11.99% in 2022. Its’ total assets recorded a negative growth of 4.44%. In 2022, Herba Drug, s.r.o.’s net profit margin decreased by 7.85%.

Headquarters
Mlynska 1335
Smizany; Kosicky; Postal Code: 05311

Contact Details: Purchase the Herba Drug, s.r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Herba Drug, s.r.o. report to view the information.
Outstanding Shares:
Purchase the Herba Drug, s.r.o. report to view the information.
Registered Capital:
Purchase the Herba Drug, s.r.o. report to view the information.
Incorporation Date:
April 30, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Herba Drug, s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.99%
Total operating revenue
1.75%
Operating profit (EBIT)
-90.14%
EBITDA
-66.95%
Net Profit (Loss) for the Period
-99.31%
Total assets
-4.44%
Total equity
-2.59%
Operating Profit Margin (ROS)
-9.38%
Net Profit Margin
-7.85%
Return on Equity (ROE)
-32.43%
Debt to Equity Ratio
5.64%
Quick Ratio
-0.01%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?